Aquestive Therapeutics, Inc. (AQST)
5.34
-0.01
(-0.19%)
USD |
NASDAQ |
Sep 04, 16:00
5.34
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics SG&A Expense (TTM) : 73.11M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 73.11M |
| March 31, 2026 | 71.75M |
| December 31, 2025 | 79.85M |
| September 30, 2025 | 63.04M |
| June 30, 2025 | 59.91M |
| March 31, 2025 | 58.56M |
| December 31, 2024 | 50.18M |
| September 30, 2024 | 43.72M |
| June 30, 2024 | 38.98M |
| March 31, 2024 | 34.98M |
| December 31, 2023 | 31.75M |
| September 30, 2023 | 34.01M |
| June 30, 2023 | 39.09M |
| March 31, 2023 | 47.31M |
| December 31, 2022 | 52.88M |
| September 30, 2022 | 56.05M |
| June 30, 2022 | 55.72M |
| March 31, 2022 | 53.26M |
| December 31, 2021 | 53.48M |
| Date | Value |
|---|---|
| September 30, 2021 | 54.08M |
| June 30, 2021 | 53.75M |
| March 31, 2021 | 54.51M |
| December 31, 2020 | 55.89M |
| September 30, 2020 | 56.78M |
| June 30, 2020 | 58.70M |
| March 31, 2020 | 61.05M |
| December 31, 2019 | 64.34M |
| September 30, 2019 | 66.57M |
| June 30, 2019 | 65.20M |
| March 31, 2019 | 82.60M |
| December 31, 2018 | 72.26M |
| September 30, 2018 | 61.13M |
| June 30, 2018 | 54.94M |
| March 31, 2018 | 21.30M |
| December 31, 2017 | 19.85M |
| September 30, 2017 | 12.29M |
| June 30, 2017 | 6.128M |
| March 31, 2017 | 6.128M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| LENZ Therapeutics, Inc. | 151.57M |
| ANI Pharmaceuticals, Inc. | 324.76M |
| Corcept Therapeutics, Inc. | 556.47M |
| Veru, Inc. | 16.05M |
| Johnson & Johnson | 25.14B |